FILACCHIONI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.813
EU - Europa 5.257
AS - Asia 3.489
SA - Sud America 352
AF - Africa 115
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 44
Totale 18.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.694
RU - Federazione Russa 1.625
SG - Singapore 932
IT - Italia 886
CN - Cina 823
SE - Svezia 649
HK - Hong Kong 532
VN - Vietnam 525
IE - Irlanda 513
UA - Ucraina 472
DE - Germania 334
KR - Corea 306
BR - Brasile 290
GB - Regno Unito 208
FI - Finlandia 201
FR - Francia 159
PL - Polonia 143
IN - India 141
AU - Australia 72
CA - Canada 66
JO - Giordania 65
SC - Seychelles 35
BD - Bangladesh 32
TR - Turchia 32
JP - Giappone 26
AR - Argentina 22
CI - Costa d'Avorio 22
MX - Messico 22
MA - Marocco 21
CH - Svizzera 14
ZA - Sudafrica 14
IQ - Iraq 13
NL - Olanda 13
VE - Venezuela 10
ES - Italia 8
PH - Filippine 8
AT - Austria 7
EG - Egitto 7
ID - Indonesia 7
UZ - Uzbekistan 7
CO - Colombia 6
EC - Ecuador 6
GT - Guatemala 6
BE - Belgio 5
CL - Cile 5
PK - Pakistan 5
PY - Paraguay 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
HN - Honduras 4
JM - Giamaica 4
LT - Lituania 4
MY - Malesia 4
NA - Namibia 4
PE - Perù 4
CR - Costa Rica 3
DZ - Algeria 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AI - Anguilla 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MM - Myanmar 1
MQ - Martinica 1
MU - Mauritius 1
Totale 18.096
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.052
Ashburn 742
Jacksonville 695
Singapore 640
Fairfield 600
Dublin 512
Chandler 467
Hong Kong 421
Seoul 292
Cambridge 291
Seattle 283
Woodbridge 268
Wilmington 241
Dong Ket 212
Milan 207
Beijing 202
Hefei 179
Buffalo 177
Houston 177
Los Angeles 172
San Jose 170
Council Bluffs 156
Warsaw 140
Princeton 121
The Dalles 115
Ann Arbor 114
Ho Chi Minh City 102
Boardman 100
Lauterbourg 100
Mumbai 90
Medford 82
Rome 79
Hanoi 72
Melbourne 72
Altamura 65
Boston 65
Helsinki 56
Shanghai 54
Kent 53
Lawrence 48
Columbus 45
Moscow 44
Munich 41
Philadelphia 37
San Diego 34
Turin 34
New York 28
West Jordan 28
Frankfurt Am Main 26
Norwalk 26
São Paulo 26
Tokyo 23
Abidjan 22
Auburn Hills 21
Turku 21
Verona 21
Dallas 20
Naples 20
Figino 19
Florence 19
Orem 18
Paris 18
Washington 18
Toronto 17
Venice 16
Bologna 15
Chennai 14
Palermo 14
Bern 13
Da Nang 13
Izmir 13
Montreal 13
Phoenix 13
Guangzhou 12
Haiphong 12
Hillsboro 12
Tianjin 12
Brooklyn 11
Mexico City 11
Andover 10
Atlanta 10
Casablanca 10
Frankfurt am Main 10
Rio de Janeiro 10
Incheon 9
London 9
San Francisco 9
Amman 8
Baghdad 8
Chicago 8
Genoa 8
Islington 8
Johannesburg 8
Salerno 8
Yubileyny 8
Belo Horizonte 7
Düsseldorf 7
Miano 7
Redondo Beach 7
Tashkent 7
Totale 11.680
Salva come PNG Salva come JPEG
Nome #
The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists. 332
1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists. 284
1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives. 260
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazolines as glycine/N-methyl-D-aspartic acid receptor antagonists 255
1,3-DIARYLPYRAZOLO[4,5-C]- AND -[5,4-C]QUINOLIN-4-ONES. 4. SYNTHESIS AND SPECIFIC INHIBITION OF BENZODIAZEPINE RECEPTOR BINDING. 251
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold to obtain Potent and Selective Human A3 Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition† 251
The 1,2,4-Triazolo[4,3-a]quinoxalin-1-one Moiety as an Attractive Scaffold to Develop New Potent and Selective Human A3 Adenosine Receptor Antagonists: Synthesis, Pharmacological and Ligand-Receptor Modeling Studies. 250
“1,2,4-TRIAZOLO[1,5-A]QUINOXALINE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AS ADENOSINE RECEPTOR ANTAGONISTS” 217
1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation and molecular modeling study 213
Structural Investigation of the 7-Chloro-3-hydroxy-1H-quinazoline-2,4-dione Scaffold to Obtain AMPA and Kainate Receptor Selective Antagonists. Synthesis, Pharmacological and Molecular Modeling Studies 201
Synthesis and binding activity of some pyrazolo[1,5-c]quinazolines as tools to verify an optional binding site of a benzodiazepine receptor ligand. 197
PYRAZOLO[4,5-C]QUINOLINES. SYNTHESIS AND SPECIFIC INHIBITION OF BENZODIAZEPINE RECEPTOR BINDING. 197
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists 194
4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones. Excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity 190
Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4-oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists 188
SYNTHESIS OF PYRAZOLO[4,5-D]- AND PYRAZOLO[4,5-C][1]BENZAZEPINE DERIVATIVES. IV. 184
Structure-activity relationship studies of novel pyrazolo[1,5-c][1,3]benzoxazines: synthesis and benzodiazepine receptor affinity. 183
SYNTHESIS AND BINDING STUDY OF PYRAZOLO[4,5-C][1,8]NAPHTHYRIDINES. 183
SYNTHESIS, BINDING STUDIES, AND STRUCTURE ACTIVITY RELATIONSHIPS OF 1-ARYL- AND 2-ARYL[1]BENZOPYRANOPYRAZOL-4-ONES, CENTRAL BENZODIAZEPINE RECEPTOR LIGANDS. 182
SYNTHESIS OF 5H-10,11-DIHYDROPYRAZOLO[5,1-C][1,4]BENZODIAZEPINE DERIVATIVES. II. 181
“3-Hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists” 181
PYRAZOLO[4,5-C]QUINOLINES. 3. SYNTHESIS, RECEPTOR BINDING, AND 13C-NMR STUDY. 181
Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: synthesis and structure-activity relationships 180
2-Aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists 179
TRICYCLIC HETEROCYCLIC SYSTEMS: PYRAZOLO[5',4':4,5]- AND PYRAZOLO[3',4':4,5]PYRANO[2,3-B]PYRIDINE DERIVATIVES. 178
Benzodiazepine binding activity of some tricyclic heteroarometic systems to define the hydrogen bonding strength of the proton donors of the receptor site. 177
7-Chloro-4,5-dihydro-8-(1,2,4-triazol-4-yl)-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates as novel highly selective AMPA receptor antagonists. 177
SYNTHESIS OF 1,5-DIARYL-3-METHYL-1H-PYRAZOLO[4,5-C]ISOQUINOLINES AND STUDIES OF BINDING TO SPECIFIC PERIPHERAL BENZODIAZEPINE BINDING SITES. 177
SYNTHESIS AND CARBON-13 NMR STUDY OF PYRAZOLO[4,5-C]- AND PYRAZOLO[4,3-C][1]BENZAZEPINES. III. 174
1-(3-Aminophenyl)-3-methyl[1]benzopyrano[2,3-c]pyrazol-4-one: a new selective A2 adenosine receptor antagonist. 173
SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 1-AMINOPHTHALAZINIUM SALTS AS GABAA RECEPTOR ANTAGONISTS. 172
. PYRROLNITRIN ANALOGS. XII. SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME PYRAZOLE CARBOXYLIC ACIDS. 171
STRUCTURE-ACTIVITY RELATIONSHIPS OF 1,2,4-TRIAZOLO[1,5-A]QUINOXALINES AND THEIR 1-DEAZA ANALOGS IMIDAZO[1,2-A]QUINOXALINES AT THE BENZODIAZEPINE RECEPTOR. 170
4-Amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as New Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation and Ligand-Receptor Modeling Studies. 170
4-Amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3-a] quinoxalin-1-one: a new A2A adenosine receptor antagonist with high selectivity versus A1 receptors. 169
Novel potent and highly selective human A3 adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studies 168
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists. 166
NOVEL ADENOSINE RECEPTOR LIGANDS: 1,3-DISUBSTITUTED[1]BENZOPYRANO[2,3-C]PYRAZOL-4-ONES. SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS. 164
SYNTHESIS OF SOME 2-ARYL-1,2,4-TRIAZOLO[1,5-C][1,3]BENZOXAZIN-5-ONES AS TOOLS TO DEFINE THE ESSENTIAL PHARMACOPHORIC DESCRIPTORS OF A BENZODIAZEPINE RECEPTOR LIGAND. 163
TRICYCLIC HETEROAROMATIC SYSTEMS. 1,2,4-TRIAZOLO[1,5-A]QUINOXALINE. 163
SYNTHESIS OF 5H-PYRAZOLO[5,1-C][1,4]BENZODIAZEPINE. 162
4-Amino-2-chloro-1,3,5-triazine: a new metabolite of atrazine by a soil bacterium. 162
DIPYRAZOLO[5,4-B:3',4'-D]PYRIDINES. SYNTHESIS, INHIBITION OF BENZODIAZEPINE RECEPTOR BINDING AND STRUCTURE-ACTIVITY RELATIONSHIPS. 160
TRICYCLIC HETEROAROMATIC SYSTEMS. 1,2,3,4-TETRAHYDROPYRAZOLO[4,3-C][1]BENZAZEPIN-1-ONES AS POTENTIAL ANTITUMOR AGENTS. 159
TRICYCLIC HETEROAROMATIC SYSTEMS: SYNTHESIS, [3H]FLUNITRAZEPAM BRAIN MEMBRANE BINDING INHIBITION, AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 2,3-DIHYDRO-2-ARYL-4-R-[1]BENZOPYRANO[4,3-C]PYRAZOL-3-ONES. 158
Atrazine metabolism by Nocardia: elucidation of initial pathway and synthesis of potential metabolites. 158
Synthesis and Pharmacological Studies at the Gly/NMDA, AMPA and Kainate Receptors of New Oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring 156
Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a New Scaffold To Develop Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand-Receptor Modeling Studies. 156
TRICYCLIC HETEROAROMATIC SYSTEMS: [1]BENZOPYRANOPYRAZOL-4-ONES AS BENZODIAZEPINE RECEPTOR LIGANDS. 155
THE CORRECT SYNTHESIS OF 2,3-DIHYDRO-2-ARYL-4-R-[1]BENZOPYRANO[4,3-C]PYRAZOLE-3-ONES. 155
REACTION OF 1-AMINOPHTHALAZINES WITH A-HALOCARBONYL COMPOUNDS: IMIDAZO-2,1-A]PHTHALAZINES AND THEIR BENZODIAZEPINE RECEPTOR ACTIVITIES. 155
TRICYCLIC HETEROAROMATIC SYSTEMS. 5H-1,2,4-TRIAZOLO[5,1-C][1,4]BENZODIAZEPINE. 154
Synthesis, glycine/NMDA and AMPA binding activity of some new 2,5,6-trioxopyrazino[1,2,3-de]quinoxalines and of their restricted analogs 2,5-dioxo- and 4,5-dioxoimidazo[1,5,4-de]quinoxalines. 154
TRICYCLIC HETEROAROMATIC SYSTEMS. 5H-1,2,3-TRIAZOLO[5,1-C][1,4]BENZODIAZEPINE. 154
Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor antagonists. 154
SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 4-CYCLOALKYLAMINO-1,2,4-TRIAZOLO[4,3-A]QUINOXALIN-1-ONE DERIVATIVES AS A1 AND A3 ADENOSINE RECEPTOR ANTAGONISTS. 153
TRICYCLIC HETEROAROMATIC SYSTEMS. SYNTHESIS AND A1 AND A2A ADENOSINE BINDING ACTIVITIES OF SOME 1-ARYL-1,4-DIHYDRO-3-METHYL[1]BENZOPYRANO[2,3-C]PYRAZOL-4-ONES, 1-ARYL-4,9-DIHYDRO-3-METHYL-1H-PYRAZOLO[3,4-B]QUINOLIN-4-ONES, AND 1-ARYL-1H-IMIDAZO[4,5-B]QUINOXALINES. 152
Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists. 151
PYRROLNITRIN ANALOGS. X. SYNTHESIS AND BIOLOGICAL ACTIVITY OF 1-CHLOROPHENYL-3- OR -5-NITROPHENYLPYRAZOLE-4-CARBOXYLIC ACIDS. 151
Chemical and biological degradation of primary metabolites of atrazine by a Nocardia strain. 150
New 2-Arylpyrazolo[3,4-c]quinoline Derivatives as Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation and Ligand-Receptor Modeling Studies. 149
Tandem 3D-QSARs Approach as a Valuable Tool To Predict Binding Affinity Data: Design of New Gly/NMDA Receptor Antagonists as a Key Study. 149
Tricyclic heteroaromatic systems. Synthesis and benzodiazepine receptor affinity of 2-substituted-1-benzopyrano[3,4-d]oxazol-4-ones, -thiazol-4-ones, and –imidazol-4-ones. 149
Tricyclic heteroaromatic systems. 1,2,4-triazolo[4,3-a]quinoxalines and 1,2,4-triazino[4,3-a]quinoxalines: synthesis and central benzodiazepine receptor activity. 148
PYRROLNITRIN ANALOGS. IX. SYNTHESIS AND BIOLOGICAL ACTIVITY OF 1-TOLYL-3-NITROPHENYL-5-METHYLPYRAZOLE-4-CARBOXYLIC ACIDS AND 1-TOLYL-3-METHYL-5-NITROPHENYLPYRAZOLE-4-CARBOXYLIC ACIDS. FARMACO, EDIZIONE SCIENTIFICA (1984), 39(10), 888-900. 147
Scouting Human A3 Adenosine Receptor Antagonist Binding Mode Using a Molecular Simplification Approach: From Triazoloquinoxaline to a Pyrimidine Skeleton as a Key Study 147
SYNTHESIS AND BINDING STUDIES OF 1-ARYLPYRAZOLO[4,5-C]- AND 2-ARYLPYRAZOLO[4,3-C]QUINOLIN-4-ONES. 145
Antiblastic agents. XXXVI. Anthramycin and analogous compounds. 1. Synthesis of 10,11-dihydro-5H-pyrrolo-[2,1-s][1,4]-benzodiazepine. 145
[1]Benzopyrano-pyrazole-4-ones. Synthesis, binding studies and structure-activity relationships 142
Synthesis, Ionotropic glutamate receptor binding affinity and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogue of TQX-173 140
TRICYCLIC HETEROAROMATIC SYSTEMS. [1]BENZOPYRANOPYRROL-4-ONES AND [1]BENZOPYRANO-1,2,3-TRIAZOL-4-ONES AS BENZODIAZEPINE RECEPTOR LIGANDS. SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS. 140
Tricyclic heteroaromatic systems. Pyrazolo[3,4-c]quinolin-4-ones and pyrazolo[3,4-c]quinoline-1,4-diones: synthesis and benzodiazepine receptor activity. 139
Antiblastic substances. LII. Tylophorine analogs. 1. Synthesis and cytostotic and cytotoxic activity of 4-(3,4-dimethoxyphenyl)piperidine. 137
Momento dipolare e aree idrofobiche in relazione con l'affinità e l'effetto biologico di ligandi del recettore benzodiazepinico 137
STUDY OF SUBSTANCES WITH ANTITUMOR ACTIVITY. LXIV. DERIVATIVES OF 9H-PYRROLO[1,2-A]INDOLE. 136
Pyrrolnitrin analogs. I. Reaction of N-(p-nitrophenacyl)aniline with acetoacetic ester. 136
TRICYCLIC HETEROAROMATIC SYSTEMS PYRAZOLO[1,5-A]QUINOXALINES: SYNTHESIS AND BENZODIAZEPINE RECEPTOR ACTIVITY. 135
TRICYCLIC HETEROAROMATIC SYSTEMS. 2-PHENYL-1,2,4-TRIAZOLO[1,5-C][1,3]BENZOXAZIN-5-ONE: A NOVEL BENZODIAZEPINE RECEPTOR LIGAND. 134
Synthesis of some tricyclic heteroaromatic systems and their A1 and A2a adenosine binding activity. 134
[1]Benzopyrano-pyrazole-3-ones. Correct and generalized synthetic metod 134
Pyrrolnitrin analogs. V. Knorr's pyrrole condensation between N-(4-nitrophenacyl)-3,5-dimethylaniline and ethyl acetoacetate. 133
Synthesis and Structure-Activity Relationships of a new set of 2-arylpyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists. 133
PYRROLNITRIN ANALOGS. VII. ETHYL 1,4- AND 1,5-DIARYL-2-METHYLPYRROLE-3-CARBOXYLATES FROM PHENACYLARYLAMINES AND ETHYL ACETOACETATE. 132
PYRROLNITRIN ANALOGS. VIII. SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF NEW 1,4- AND 1,5-DIARYLPYRROLES. 131
Synthesis and biological activity of some 3-(pyrazol-1'-yl)indazole derivatives 131
Synthesis of 4-amino-6-(hetero)arylalkylamino-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent A2A adenosine receptor antagonists. 131
Synthesis and structure-activity relationships of a new set of 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as adenosine receptor antagonists. 130
Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazolin-2,4-diones as glycine-NMDA antagonists: a pharmacophore model based approach. 129
TRICYCLIC HETEROAROMATIC SYSTEMS 1,2,4-TRIAZOLO[1,5-A]QUINOXALINES: SYNTHESIS AND BENZODIAZEPINE RECEPTOR ACTIVITY. 127
Nitrogen heterocycles. IX. Synthesis of 5-hydroxy-2,4-dicarbethoxypyrroles. 127
STUDY OF SUBSTANCES WITH ANTITUMOR ACTIVITY. LXV. THE 2-(4-NITROBENZOYL)INDOLIN-3-ONES BY CYCLIZATION OF N-ACETYL- N-(4-NITROPHENACYL)ANTHANILIC METHYL ESTER DERIVATIVES. 123
Synthesis of pyrrolnitrin analogs. III. Preparation and antibacterial properties of 1,3-diaryl-substituted maleimides. 123
Synthesis of 3-substituted 1,2,4,5-tetrahydro-2,5-dioxo-3H-1,4-benzodiazepines. 119
Tricyclic heteroaromatic systems. Synthesis and adenosine receptor binding evaluation of some pyrazolo-quinoline and [1]benzopyrano-pyrazole derivatives 115
Synthesis and A1 and A2A binding activity of some pyrano[2,3-c]pyrazol-4-ones. 114
Tricyclic Heteroaromatic systems. 3-Substituted 1,2,3,5,6,7-hexahydro-2,5,6-trioxopyrazino[1,2,3-de]quinoxalines as novel antagonists at the glycine-NMDA site. 113
Tricyclic heteroaromatic systems. Synthesis and benzodiazepine binding activity of 1-substituted-3-methyl- and 3-phenylpyrazolo[4,5-c]quinolin-4-ones. 112
Synthesis of 2-substituted-3,4-dihydro-3-oxo-6,8-dichloro-2H-1,4-benzothiazin-1,1-dioxides and 1-oxides as glycine-NMDA receptor antagonists. 112
Psychotropic-active compounds. I. Synthesis of 5-phenylpyrrolo[2,1-d][1,5]benzothiazepine 6,6-dioxide and 1,4 dioxo-1,2,3,3a,4,5-hexahydro-5-phenylpyrrolo[2,1-d][1,5]benzothiazepine 6,6-dioxide, derivatives of a new heterocyclic system 110
Compounds with psychotropic activity. III. Synthesis of a new heterocyclic system. 4H-pyrrolo[2,1-c][1,4]benzothiazine. 109
Totale 16.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022652 0 87 23 47 23 26 26 54 26 20 149 171
2022/20231.916 181 225 77 133 219 381 290 98 237 6 43 26
2023/2024774 34 97 132 45 31 152 14 174 12 29 40 14
2024/20254.933 156 491 282 632 1.598 844 77 242 186 125 169 131
2025/20264.735 670 754 517 244 450 160 455 232 263 222 94 674
2026/2027314 133 181 0 0 0 0 0 0 0 0 0 0
Totale 18.144